ArticleFrontiers in global women's health2026
Maternal migraine, vascular comorbidities, and prematurity: exploring overlooked associations in pregnancy.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prematurity remains a leading cause of neonatal morbidity and mortality, with lasting implications for neurodevelopment and lifelong health. This study aimed to investigate maternal and fetal factors associated with preterm birth within a cohort of pregnant women affected by migraine, with particular focus on vascular and metabolic comorbidities potentially contributing to adverse pregnancy outcomes. Methods: We performed prospective cohort study. Pregnant women presenting in the first trimester (≤11 weeks gestation) with a history of migraine prior to conception and at least one migraine attack during the first trimester were enrolled. Participants underwent neurological evaluation to exclude secondary headache disorders and completed structured questionnaires on migraine frequency and intensity pregestation and during pregnancy. Participants were stratified by gestational age at delivery into preterm (<37 weeks) and term (≥37 weeks) groups. Maternal, fetal, and pregnancy-related variables assessed included maternal age, parity, maternal obesity, gestational weight gain, fetal growth restriction, delivery mode, pregnancy-induced hypertension, and gestational diabetes mellitus. Results: A total of 400 women were included, of whom 65 delivered preterm. Statistically significant associations with preterm delivery were observed for pregnancy-induced hypertension ( Conclusions: Our findings support the hypothesis that migraine is a systemic vascular condition with significant implications for pregnancy outcomes. The coexistence of migraine with pregnancy-induced hypertension, gestational diabetes mellitus and maternal obesity suggests that shared pathophysiological mechanisms may increase the risk of prematurity. While pre-pregnancy obesity alone was not an independent predictor, gestational weight gain represents a critical modifiable factor. These results underscore the need for individualized, multidisciplinary prenatal care for women with migraine, emphasizing vascular risk assessment, blood pressure monitoring, weight management, and optimized migraine control. Future studies are warranted to clarify causal mechanisms and develop safe therapeutic strategies to protect both maternal and fetal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.